Biphasic effects of propranolol on tumour growth in B16F10 melanoma‐bearing mice
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Pharmacology"
DOI: 10.1111/bph.13662
Abstract: Propranolol is a vasoactive drug that shows antiangiogenic and antitumour activities in melanoma. However, it is unknown whether these activities are dose‐dependent and whether there is a relationship between systemic vascular effects of propranolol and… read more here.
Keywords: melanoma; effects propranolol; growth b16f10; propranolol tumour ... See more keywords